Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BA058 phase 3 fracture prevention study in postmenopausal women with severe osteoporosis
2010-022576-30Phase 3Completed
- Sponsor
- Radius Health Inc
- Start
- Jan 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of abaloparatide in postmenopausal osteoporosis (3 arms), sponsored by Radius Health Inc. Primary endpoint: New vertebral fracture incidence at end of treatment. Started Jan 2011; status: completed.
02
Drugs
abaloparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2010-022576-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022576-30.